Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Authors' reply

Affiliations

¹ Department of Medicine, Center for Innovation in Access and Quality, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA; GI Health, Outcomes, Policy and Economics (GI-HOPE) Program, Division of Gastroenterology, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA. justin.sewell@ucsf.edu.

Comment

J L Sewell et al. Aliment Pharmacol Ther. 2014 Feb.

. 2014 Feb;39(4):442-3.

doi: 10.1111/apt.12591.

¹ Department of Medicine, Center for Innovation in Access and Quality, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA; GI Health, Outcomes, Policy and Economics (GI-HOPE) Program, Division of Gastroenterology, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA. justin.sewell@ucsf.edu.

No abstract available

Comment on

Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.
Shah SC, Day LW, Somsouk M, Sewell JL. Shah SC, et al. Aliment Pharmacol Ther. 2013 Oct;38(8):925-34. doi: 10.1111/apt.12479. Epub 2013 Sep 4. Aliment Pharmacol Ther. 2013. PMID: 24004101 Free PMC article.
Letter: Treatment for small intestinal bacterial overgrowth--where are we now?
Furnari M, Savarino V, Savarino E. Furnari M, et al. Aliment Pharmacol Ther. 2014 Feb;39(4):442. doi: 10.1111/apt.12585. Aliment Pharmacol Ther. 2014. PMID: 24447318 No abstract available.